Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.7M
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
13.3M
-
Shares change
-
+4.67M
-
Total reported value, excl. options
-
$24.4M
-
Value change
-
+$7.46M
-
Put/Call ratio
-
0.23
-
Number of buys
-
54
-
Number of sells
-
-32
-
Price
-
$1.83
Significant Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) as of Q4 2024
126 filings reported holding INO - INOVIO PHARMACEUTICALS, INC. - Common Stock as of Q4 2024.
INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.3M shares
of 52.7M outstanding shares and own 25.33% of the company stock.
Largest 10 shareholders include Deep Track Capital, LP (3.12M shares), BlackRock, Inc. (1.91M shares), VANGUARD GROUP INC (1.67M shares), Stonepine Capital Management, LLC (1.05M shares), AIGH Capital Management LLC (654K shares), BANK OF AMERICA CORP /DE/ (641K shares), GEODE CAPITAL MANAGEMENT, LLC (629K shares), STATE STREET CORP (504K shares), HIGHBRIDGE CAPITAL MANAGEMENT LLC (300K shares), and GOLDMAN SACHS GROUP INC (290K shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.